Received Feb 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | Z92L4 | — |
Menveo expired dose administration (less than 30 days since expiration); This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number Z92L4, expiry date 31-JAN-2026) for prophylaxis. On 03-FEB-2026, the patient received Menveo. On 03-FEB-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo expired dose administration (less than 30 days since expiration)). The outcome of the expired vaccine used was not applicable.